Zimbabwe has declined a significant US health deal worth $367m (272 million pounds) spanning five years because of the United States' request for confidential data.
This move was revealed following a government memo from December was disclosed, indicating that President Emmerson Mnangagwa believed the arrangement was "lopsided".
A government spokesperson later stated that the US was seeking health data for scientific study and commercial purposes but refused to guarantee the resulting advantages from future vaccines.
"We are forced to start the challenging and unfortunate task of ending our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for more dialogue to reach a agreement agreeable to all parties so the nation's critical HIV programme can continue.
Wider Context
This rejection comes after a comparable case in Kenya, where a court suspended a similar health funding agreement following concerns were raised about the security of Kenyans' health data.
Since resuming the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
USAID had overseen aid for the American government, but Trump argued its spending was "wasteful" and his administration was pursuing government-to-government agreements to boost openness and accountability.
Based on reports, 16 nations in Africa have to date agreed to similar agreements, representing more than $18.3bn of fresh investment.
Specifics of the Declined Deal
The money for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership would have delivered immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment via US-supported initiatives," Tremont added.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"The proposal required Zimbabwe to surrender its biological resources and data over an extended period, with no corresponding assurance of access to any scientific breakthroughs – like new medicines or tests – that could result from that provided information," he stated.
"Effectively, our country would provide the basic resources for medical research with no certainty that the end products would be accessible to our people if a new health crisis emerge."
National Interest and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were disrupting systems previously set up via the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system created to deal with future pandemics.
"This system is designed to ensure that when a nation contributes its data, the benefits – including medicines and cures – are shared equitably, not monopolised exclusively by those with the capability to create them."
The government's concerns regarding the US deal "are not meant as opposition to America," he added.
"We are open to ongoing dialogue with our American counterparts on how subsequent co-operation might be arranged in a way that respects the sovereignty and dignity of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but recommended that talks need to persist since a large portion of the country's Aids initiatives relied on international support.
"In cases where specific concerns exist, such as those involving information security or agreement terms, these can often be addressed through technical clarification and mutually agreed protections," the group commented.
This impasse underscores the complex challenges between accepting much-needed foreign assistance and safeguarding local interests in an increasingly interconnected world.